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Abstract
This article considers the utility of the bounded cumulative hazard model in cure rate estimation,
which is an appealing alternative to the widely used two-component mixture model. This approach
has the following distinct advantages: (1) It allows for a natural way to extend the proportional
hazards regression model, leading to a wide class of extended hazard regression models. (2) In
some settings the model can be interpreted in terms of biologically meaningful parameters. (3) The
model structure is particularly suitable for semiparametric and Bayesian methods of statistical
inference. Notwithstanding the fact that the model has been around for less than a decade, a large
body of theoretical results and applications has been reported to date. This review article is
intended to give a big picture of these modeling techniques and associated statistical problems.
These issues are discussed in the context of survival data in cancer.
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1. INTRODUCTION
In many clinical and epidemiological settings, investigators observe cause-specific survival
curves that tend to level off at a value strictly greater than 0 as time increases. A prominent
example of this pattern is shown in Figure 1(a). A well-pronounced plateau in this display of
the Kaplan–Meier curve may be thought of as an indication of the presence of a proportion
of patients for whom the disease under study will never recur. Alternatively, one can
consider such patients to be cured. Clearly, estimating the proportion of cured patients may
have important medical implications. In addition, clinical covariates may exert dissimilar
effects on the probability of cure and the timing of tumor relapse or other events of interest.
This is apparent from Figure 1(b), where two survival curves for patients with localized
breast cancer stratified by age are presented. These plots suggest that the two categories of
patients are likely to have a similar probability of cure, whereas a short-term effect of age at
diagnosis on cancer-specific survival is highly plausible. It is also clear that the commonly
used proportional hazards model fails to fit the data shown in Figure 1(b). In Section 3.3 we
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present a detailed example involving prostate cancer survival that has major biomedical
implications. Such an advance would have not been possible to make without invoking the
concept of cure. The preceding examples suggest at least two advantages that survival
models have for allowing for the presence of cured individuals: (1) They enrich our ability
to interpret survival analysis in terms of characteristics that have a clear biomedical
meaning; (2) they lead to more general regression models, thereby extending our ability to
describe actual data. The latter contention holds whether the probability of cure is
significantly separated from 0 (see Sec. 3).
To develop relevant methods of statistical data analysis, one has to provide a rigorous
definition of cure rate. In this article, we will proceed from the most widely accepted
concept of biological cure. The probability of (biological) cure, variously referred to as the
cure rate or the surviving fraction, is defined as an asymptotic value of the survival function
Ḡ(t) as t tends to ∞. Let X be the survival time with cumulative distribution function (c.d.f.)
G(t) = 1 − Ḡ(t). Under a continuous model the existence of a nonzero surviving fraction, p,
is determined by the behavior of the hazard function, λ(t), by virtue of the equality
(1.1)
Whenever p > 0 the underlying survival time distribution is said to be improper. Clearly,
λ(u) → 0 as u → ∞ if p > 0 and the limit of λ(u) (as u → ∞) exists. Formulated in terms of
the marginal failure time distribution, this definition does not imply that the overall survival
time may be infinite, because the time to death from other causes (censoring time) is finite
with probability 1. Therefore, the distribution of the observed lifetime in the presence of
competing risks is always proper, and there is no defiance of common sense.
Boag (1949) and later Berkson and Gage (1952) proposed a two-component (binary)
mixture model for the analysis of survival data when a proportion of patients are cured.
Since then, the binary mixture-based approach has become the dominant one in the literature
on cure models (Miller 1981; Farewell 1982; Goldman 1984; Greenhouse and Wolfe 1984;
Gamel, McLean, and Rosenberg 1990; Gordon 1990; Bentzen, Johansen, Overgaard, and
Thames 1991; Goldman and Hillman 1992; Kuk and Chen 1992; Laska and Meisner 1992;
Maller and Zhou 1992, 1994, 1995, 1996; Sposto, Sather, and Baker 1992; Yamaguchi
1992; Gamel and Vogel 1993; Gamel, Vogel, Valagussa, and Bonadonna 1994; Chappell
Nondahl, and Fowler 1995; Taylor 1995; Gamel, Meyer, Feuer, and Miller 1996; Peng and
Dear 2000; Sy and Taylor 2000, 2001, to name a few). The main idea behind this approach
is that any improper survival function can be represented as
(1.2)
where M is a binary random variable taking on the values of 0 and 1 with probability p and 1
− p, respectively, with
and Ḡ0(t) is defined as the survival function for the time to failure conditional upon ultimate
failure, that is,
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When designing regression counterparts of model (1.2), it is common practice to use the
logistic regression model for incorporating covariates into the probability p, and
proportional hazards regression for modeling the effect of the covariates on the conditional
survival function Ḡ0.
An alternative, but equally general, representation of an improper survival time distribution
can be obtained by assuming that the cumulative hazard  has a finite positive
limit, say θ, as t tends to ∞. In this case one can write
(1.4)
where F(t) = Λ(t)/θ is the c.d.f. of some nonnegative random variable such that F(0) = 0. In
what follows we will call the model given by (1.4) the bounded cumulative hazard (BCH)
model.
Within the nonparametric framework it makes no difference whether representation (1.2) or
(1.4) is used as a basis for the estimation of p, but the situation is not the same when Ḡ0(t) is
parametrically specified. Using definition (1.3), one can represent the survival function (1.4)
in the form of formula (1.2), but both p and Ḡ0 become functions of the common parameter
θ:
A similar confounding occurs when one represents (1.2) in the form of (1.4). A summary of
useful formulas showing the relationship between the two models was given in Chen,
Ibrahim, and Sinha (1999).
Although the models given by (1.2) and (1.4) are just two different ways of rescaling the
survival function Ḡ(t), it took a long time to realize some virtues of the BCH model (which
will be discussed later), which is the main subject matter of the present article. The first
move in this direction was due to Haybittle (1959,1965). The author proceeded from the
observation that in some clinical data on cancer survival, an actuarial estimate of the hazard
function tends to decrease exponentially with time. If the same property holds for the true
hazard, expression (1.4) assumes the form:
(1.5)
A comprehensive treatment of this model was given by Cantor and Shuster (1992) who used
the following parameterization:
(1.6)
Tsodikov et al. Page 3













where β > 0, but ζ may take either sign. If ζ > 0 the survival function (1.6) corresponds to the
proper Gompertz distribution, but if ζ < 0 the distribution is improper with the surviving
function equaling eβ/ζ. For this reason the distribution given by (1.6) can be called a
generalized Gompertz distribution. In more recent work Cantor (2001) used
representation(1.6) to determine the projected variance of estimated survival probabilities in
clinical trials. A generalization of the model (1.6) was proposed by Cantor (1997) who
suggested approximating a log hazard by a polynomial to obtain an estimate of the cure rate
based on formula (1.1).
Clearly, the Gompertz-like model given by formula (1.5) is a special case of formula (1.4)
with the function F(t) specified by an exponential c.d.f. with parameter ζ. The representation
(1.4) was first introduced in an article of Yakovlev et al. (1993) and discussed later as an
alternative to the mixture model by Yakovlev (1994). Interestingly enough, Yakovlev et al.
(1993) proceeded from purely biological considerations; the idea of imposing a constraint on
the behavior of the hazard function was introduced later in Tsodikov, Loeffler, and
Yakovlev (1998b). In fact, the authors proposed a simple mechanistically motivated model
of tumor recurrence yielding an improper survival time distribution. Under this model the
probability of tumor cure is defined as the probability of no clonogenic tumor cells
(clonogens) surviving by the end of treatment. The cell is called clonogenic if it is capable of
producing a cell clone, that is, a group of cells that have this cell as their common parent.
There is biological evidence that the majority of recurrent tumors are clonal in origin; that is,
they arise from a single progenitor cell. In cancer studies the primary endpoint is
conventionally the time to failure, referred to as survival time or failure time, X, with the
event of failure being either tumor recurrence (disease-free survival) or death caused by the
cancer under study (cancer-specific survival). According to the clonal model of
posttreatment tumor development proposed by Yakovlev et al. (1993), a recurrent tumor
arises from a single clonogenic cell. Every surviving clonogen can be characterized by a
latent time (termed the progression time) during which it could potentially propagate into an
overt tumor. Let M be the number of clonogens remaining in a treated tumor and ϕM be its
probability generating function (p.g.f.). Assuming that progression times for surviving
clonogens are independent and identically distributed (i.i.d.) with a common survival
function F̄, one can find easily that G(t) = ϕM (F̄(t)), t ≥ 0. This formula suggests that
knowledge of the entire distribution of the number of surviving clonogens is critical for
developing biologically motivated survival models with cure. In particular, suppose that M
is Poisson distributed. Then the survival function Ḡ(t) is given by the BCH model (1.4) with
the parameter θ interpreted as the mean number of surviving clonogens.
A more general mechanistic model was considered by Hanin (2001). Suppose a tumor
initially comprising a nonrandom number i of clonogenic cells is exposed to a fractionated
radiation schedule consisting of n instantaneously delivered equal doses D separated by
equal time intervals τ. It is assumed that every cell survives each exposure to the dose D
with the same probability s = s(D), given that it survived the previous exposures, and
independently of other cells. It is also assumed that the death of irradiated tumor cells is
effectively instantaneous. Assuming, in addition, that tumor growth kinetics between
radiation exposures can be modeled as a homogeneous birth-and-death Markov process with
birth rate λ > 0 and spontaneous death rate ν ≥ 0, Hanin (2001) derived an explicit formula
for the distribution of the random variable (r.v.) M; the latter turned out to be a generalized
negative binomial distribution. The corresponding p.g.f. is of the form (Hanin 2001):
(1.7)
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suggesting the following survival function for the time to tumor recurrence
(1.8)
where a = 1 − ω − s + sωμn−1; b = s(ωμn−1 − 1), c = 1 − ω − s + sμn−1, d = s(μn−1 −1), α =
e(ν−λ)τ, μ = s/α, ω = [λ − να − s(λ − ν)]/[λ(1 − α)], F̄ (t) = 1 − F (t), satisfying the conditions:
μ ≠ 1 and λ ≠ ν. The preceding formula may be taken as the starting point for the
development of a new class of regression survival models; with this aim in mind, it makes
sense to reduce the number of baseline parameters by enforcing the conditions: F (0) = 0 and
Ḡ(0) = 1.
Clinically detectable primary tumors are estimated to contain at least i = 105 clonogenic
tumor cells ranging up to probably 109 cells or even more (Tucker 1999). On the other hand,
the probability, sn, for a cell to survive n fractions is expected to be very low, especially in
the total dose range where cures occur frequently. This provides the rationale for exploring
limiting distributions associated with model (1.8). As was shown by Hanin (2001), if n is
fixed, i → ∞ and s → 0 in such a way that there exists a limit A = limi→∞ isn, 0 < A < ∞,
then the distribution of the number of clonogens converges to a Poisson distribution with
parameter θ = A/αn−1. This result disproves the conjecture (Tucker, Thames, and Taylor
1990; Tucker and Taylor 1996; Tucker 1999) that, due to cell proliferation occurring
between fractions of radiation, the limiting distribution of the number of surviving
clonogenic cells may not be Poisson. However, the convergence to the limiting distribution
is quite slow, indicating a strong point in the line of reasoning presented by these authors.
The rate of convergence was evaluated numerically by Hanin, Zaider, and Yakovlev (2001)
in terms of the total variation distance between the exact distribution of the number of
clonogens and its Poisson limit. Another useful limiting distribution arises in the subcritical
case where μ = s/α < 1. This condition means that the total cell loss due to both causes of
cell death (radiation induced and spontaneous) prevails on average over the cell gain owing
to the proliferation of tumor cells between fractions of radiation dose. An explicit expression
of this distribution was derived by letting i → ∞ and n → ∞ so that iμn → γ, 0 < γ < ∞
(Hanin et al. 2001).
The book by Yakovlev and Tsodikov (1996) presents several applications of (1.4) with a
two- or three-parameter gamma distribution for the function F. The authors use the Hjort test
(Hjort 1990) for goodness-of-fit testing, which is a natural choice in the parametric analysis
of censored data without covariates. In a recent article, Gregori, Hanin, Luebeck,
Moolgavkar, and Yakovlev (2002) adopted the Hjort goodness-of-fit test for testing several
models of carcinogenesis. Methods of model diagnostics specially designed for different
versions of this model have yet to be explored.
In this article, the current state of the art in methodology of statistical inference based on the
BCH model is reviewed. The approach under review has emerged from cancer studies, and
this fact necessarily reflects on the focus of our discussion. The history of the BCH model is
relatively short, and the model has not yet enjoyed applications to other human diseases, to
say nothing of nonmedical applications, such as estimation of recidivism rates. However, it
should be kept in mind that other possible applications of the BCH model, including those
mentioned previously, are every bit as well justified as for the binary mixture model; there is
no reason for practitioners to refrain from using the BCH model just because it was
originally derived in the context of cancer development.
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The BCH model has the following distinct advantages:
1. It allows construction of a rich class of nonlinear transformation regression models
to describe complex covariate effects. The class includes the traditional
proportional hazards model as a special case; this structure is lacking in the binary
mixture model. This makes the BCH model a natural tool for studying and testing
departures from the proportionality of risks.
2. In some settings the BCH model provides a biologically meaningful interpretation
of the results of the data analysis. This feature is especially important for
combining statistical inference with other mathematical approaches to biomedical
problems, for example, optimization of cancer therapy.
3. The BCH model offers certain technical advantages when developing maximum
likelihood or Bayesian estimation procedures.
Before turning to the discussion of specific methods and results, one important remark is in
order here. As is evident from definition (1.1), the probability of cure is essentially an
asymptotic notion. However, the period of observation in actual truth is always finite, which
is to say that one deals here with a problem of prediction rather than with the usual type of
statistical inference. In other words, additional assumptions as to the behavior of Ḡ(t) or λ(t)
beyond the period of observation are needed. At the same time a sample of i.i.d. right-
censored observations is available, and it is natural that one tries to reduce the problem of
prediction to that of estimation.
2. NONPARAMETRIC METHODS FOR A HOMOGENEOUS SAMPLE
As was mentioned in Section 1, formula (1.2) is a general expression for any improper
survival time distribution. Proceeding from this representation, Maller and Zhou (1996)
developed a theory of nonparametric estimation of the probability p. Suppose that the
survival time distribution G(t) is absolutely continuous and let t1 < t2 < · · · < tn be a sample
(subject to right censoring) of the ordered observed failure times. Maller and Zhou (1996)
suggested estimating p by
(2.1)
where  is the Kaplan–Meier estimator of the underlying survival function. Then a
natural estimator for the conditional survival function Ḡ0(t) is given by
(2.2)
For any c.d.f. K(t) define its right extreme τK as τK = inf{t ≥ 0: K(t) = 1}. The consistency
question for the estimator p̂n is settled in the following result by Maller and Zhou (1992):
Assume that censoring is independent and 0 < p ≤ 1. Let C̄(t) be the censoring time survival
function. Let τH be the right extreme of H (t) = 1 − Ḡ(t)C̄(t) and suppose that the c.d.f. G(t) =
1 − Ḡ(t) is continuous at τH in case τH < ∞. Let G0(t) = 1 − Ḡ0(t) and C(t) = 1 − C̄(t). Then
the estimator p̂n is consistent if and only if
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Under the same conditions the authors showed that the condition τG0 ≤ τC is necessary and
sufficient for the convergence in probability of  to 0 as n tends to ∞.
Assuming the inequality (2.3) and some additional mild conditions, Maller and Zhou also
proved that, when p < 1,  is asymptotically (as n → ∞) normally distributed with
mean 0. Laska and Meisner (1992) showed that the estimator  is, in fact, the
generalized nonparametric maximum likelihood estimator of the proportion p in the mixture
model (1.2).
As discussed previously, the inequality τG0 ≤ τC is both necessary and sufficient for
consistency of the Kaplan–Meier estimator of the cure probability p. This inequality may be
thought of as a quantification of “sufficient follow-up” (Maller and Zhou 1992). If the
condition is not true, then failures may occur after the maximum follow-up period and it is
not possible to determine which proportion of the late censored data has actually been cured.
Maller and Zhou (1994) suggested a statistical test based on the length  of the interval
between the largest uncensored failure time  and the largest overall failure time tn.
Intuitively, if this interval is large, then the last failure has occurred well before the last
censoring event so there has been sufficient follow-up. Maller and Zhou showed that, under
appropriate regularity conditions, the estimator αn = (1 − Nn/n)n is an approximate p value
for a test of τG0 ≤ τC, and αn converges to 0 in probability if and only if τG0 ≤ τC. Here Nn is
the number of uncensored failure times in the interval ( ]. This test estimates a
significance level rather than controls for it, so that the original version of the test by Maller
and Zhou suggests the hypothesis of sufficient follow-up to be rejected whenever the
estimated p value exceeds a prespecified critical value, say .05. Later, after conducting
computer simulations, Maller and Zhou (1996) came to the conclusion that this test was far
too conservative. It is clear that a pertinent test should be based on percentiles of the sample
distribution of αn (or the closely related statistic qn = Nn/n) rather than on a fixed p value.
Unfortunately, the relevant sample distributions are not known even in large samples. The
idea of sufficient follow-up is intuitively compelling and a search for a more general formal
definition of this notion (which is not necessarily related to consistency of the corresponding
nonparametric estimator) should be continued.
When proceeding from the BCH model, formula (1.1) suggests the following nonparametric
estimator of the cure probability: p̃n = exp{−Λ̃n(tn)}, where Λ̃n(tn) is the Nelson–Aalen
estimator of the cumulative hazard at the point of last observation. A pertinent
nonparametric estimator for F(t) can be proposed in the form:
(2.4)
where  is the Kaplan–Meier estimator for the survival function Ḡ(t).
It is important to note that the preceding nonparametric estimators yield an estimate of
survival probability at the right end T of the observation period. This estimate is all we have
to predict the behavior of the survival function beyond the period of observation, and all
such predictions are final. If we strictly follow the formal definition of cure rate, we have to
recognize that the nonparametric approach implies a straight-line extrapolation of the
estimated survival function beyond the period of observation T : Ḡ(t) is set to be equal to a
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constant value of  for all t ≥ T. The same holds true for the semiparametric regression
models discussed in Section 3. It should also be noted that the length T of the period of
observation is implicitly involved in (2.3). Let us decompose the censoring time survival
function as follows: C̄(t) = C̄*(t)[1 − I (t − T)], where I (x) = 0 for x < 0 and I (x) = 1 for x ≥
0. Then inequality (2.3) is replaced by τG0 ≤ min{τC*, T}. The finiteness of the follow-up
period is relevant to large-sample studies, where the value of T should be kept fixed when
increasing the sample size; otherwise, ensuring asymptotic properties would imply infinite
observation time.
Another feature inherent in the nonparametric approach has to do with the instability (high
variance) of the nonparametric estimators. It is a well-known fact that the Kaplan–Meier
estimator becomes highly unstable for t close to the end of an observation period in the
presence of heavy censoring (Pepe and Fleming 1989; Cantor and Shuster 1992; Tsodikov
2001), which may have a very significant effect on the accuracy of cure rate estimation. The
method for testing for sufficient follow-up, proposed by Maller and Zhou (1994, 1996),
suffers from the same kind of instability as well. The nonparametric estimator
 is particularly sensitive to variations of  in the denominator.
Therefore, it is not recommended to use it in its original form. An improved estimator was
proposed in Tsodikov (2001). This is a two-stage estimator. First, Ḡn(tn) is estimated
parametrically. Then Ḡ(t) is estimated nonparametrically with Ḡn(tn) constrained to be equal
to the corresponding value of the parametric estimate.
3. SEMIPARAMETRIC REGRESSION SURVIVAL MODELS WITH CURE
3.1 Mixture Models and Generalizations
So far we have followed two distinct lines of reasoning in the discussion of cure models:
statistical and mechanistic. We now consider more formal relationships between the two
aspects of the problem.
A cure model can be formulated by making assumptions about either the hazard or the
survival function. For example, making the assumption on the bounded cumulative hazard in
a proportional hazards (PH) model, we obtain the so-called improper PH model
(3.1)
where β is a vector of regression coefficients, z is a vector of covariates, and θ(β, z) is a
known function relating β to z. In what follows we allow for more than one predictor, and
for an arbitrary parameterization of regression predictors. However, in the examples the
most common exponential parameterization is used, in which θ(β, z) = exp{β′ z}, where β′ is
the transposed β vector. The component β0 of the vector β = (β0, β1, …)′ is the intercept
term; therefore, z0 = 1 in the vector of covariates z = (z0, z1, …).
A general class of semiparametric regression models, nonlinear transformation models
(NTM), was proposed in Tsodikov (2002, 2003):
(3.2)
where γ(x|β, z) is some parametrically specified cumulative distribution function in x with
support on [0, 1]. Although our discussion allows for any parameterization of γ in terms of β
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and z, in the examples we assume that γ is parameterized through a set of parameters/
predictors θ, η, …, where each predictor is further parameterized using generally different
sets of regression coefficients β1, β 2, …, so that . The linear
transformation models considered by Cheng, Wei and Ying (1995) represent a subclass of
NTM with
(3.3)
where p is a tail function (=1− c.d.f.) and q is an inverse of a tail function (not necessarily
that of p). Cure models represented by the NTM class were introduced in Tsodikov (2002).
To make (3.2) a cure model, the following assumptions are made to enforce the limit Ḡ(t|β,
z) → p > 0:
(3.4)
The restriction limt→∞ F̄(t) = 0 proposed by Taylor (1995) in the context of the two-
component mixture model removes the overparameterization of the description of the
baseline cure rate through F and h and the associated estimation and convergence problems
for the fitting algorithms. Following the restriction, the estimate  is assumed to satisfy
. This restriction is also necessary for separation of the long- and short-term
covariate effects on survival. The preceding restriction should be observed when
parameterizing the model, as discussed in the following examples.
Alternatively, a cure model can be formulated as a two-stage model. First, an unobservable
random variable M is postulated with distribution p(m|β, z) that depends on covariates.
Second, the observed survival function is formed as
(3.5)
where the expectation is taken with respect to M, given z, and the distribution of M depends
on β and z. The model (3.5) represents a generalized PH frailty model, which we simply call
the PH mixture model, introduced in Tsodikov (2002,2003), where M is assumed to be an
arbitrary nonnegative random variable. In this context M can be interpreted as a missing
covariate in a PH model. Obviously, the usual PH frailty model
(3.6)
where the distribution of U is independent of covariates, is a particular case of (3.5) with M
= Uθ(β, z). Missing variables U dependent on covariates have been considered by several
authors (e.g., Wassel and Moeschberger 1993) within the shared PH frailty framework. It
should be noted that the PH mixture model (3.5), although at least as general as (3.6) with U
= U(β, z), leads to a computationally efficient estimation procedure that we consider in the
next section. Because all models considered previously in this article are particular cases of
(3.5), an estimation procedure designed for the PH mixture model, or for the NTM subclass
(3.2) restricted to (3.4), represents a universal tool for statistical inference with such models.
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The discrete mixture model [i.e., (3.5) with a discrete random variable M], which was used
in particular forms as a mechanistic model in Section 1, can be linked to the NTM class.
Observe that the p.g.f. of a discrete random variable M
is a distribution function in x with the support [0, 1]. Indeed, because the pm are
nonnegative, ϕM (x) is increasing in x. Also, . If M is discrete and
depends on covariates, (3.5) can be rewritten as an NTM with
With the discrete mixture model, the probability of cure is given by γ (0|z) = ϕM (0|β, z) =
p0(β, z).
Alternatively, we may want to write an NTM model as a discrete mixture model. It should
be noted that NTM is a wider class than that of mixture models. For an NTM to be a discrete
mixture, we may require that γ (x|β, z) be an analytic function of x on [0, 1]. As such, it can
be expanded in a power series about x = 0. Additionally, the coefficients of the
corresponding power series must be positive. Should this be the case, they can be interpreted
as probabilities, and γ as a generating function of some discrete random variable. If γ is a
mixture model (discrete or continuous), then ψ(λ) = γ (e−λ) is the Laplace transform of the
distribution of the mixing variable M. Generally, a necessary and sufficient condition for γ
(x|·) to be a mixture model is that ψ be a completely monotonic function as given by the
Bernstein theorem (see Feller 1971). A function ψ(λ) is called completely monotonic if all of
the derivatives ψ(n) exist and (−1)nψ(n)(λ) ≥ 0, λ > 0.
We can now represent the cure models discussed earlier in this article as members of the
mixture–NTM model family. It should be stressed that such a representation is not unique.
The improper PH model (3.1) corresponds to
(3.7)
This is the generating function of the Poisson distribution, and by expanding γ about x = 0,
we get a power series with Poisson probabilities as coefficients. This gives us the
mechanistic interpretation of the improper PH model discussed in Section 1.
Consider an extension of the improper PH model allowing for dissimilar covariate effects on
long- and short-term survival. To construct an extended hazard model (the term was
introduced by Etezadi-Amoli and Ciampi 1987), we employ the fact that F̄ is a survival
function. Incorporating covariates into F̄, we can add a short-term effect to the improper PH
model. The class of extended hazard models
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where γ̃ is an NTM and β = (β1, β2), βi = (βi0, βi1, …), i = 1, 2, was introduced in Tsodikov
(2002). If γ̃ is a mixture model itself, then (3.8) is also a mixture model with γ̃ = exp{− θ[1 −
γ̃]}. The mixing variable M that generates the family (3.8) has a well-defined structure of a
compound variable
(3.9)
where ν is a Poisson random variable, , and the δk are i.i.d. copies of a random
variable δ with Laplace transform γ̃(e−λ). The binary distribution for ν gives rise to the two-
component mixture class of models
(3.10)
Kuk and Chen (1992) proposed a regression model in the form of (3.10) with p being a
logistic regression and γ̃ a proportional hazards regression. This model was further studied
by Sy and Taylor (2000) and Peng and Dear (2000). The Poisson distribution for ν leads to
the bounded hazard family of mixture models. For example, let δ be degenerate
(nonrandom): Pr(δ = η(β2, z)) = 1. Then M = η(β2, z)ν, where ν is Poisson with expectation
θ(β1, z). Then we have the PHPH model
(3.11)
The model (3.11) was proposed by Broët et al. (2001) in the context of two sample score
tests for long- and short-term covariate effects.
In the preceding cure models, restriction (3.4) needs to be observed. In models (3.8)
considered so far, one predictor (η) was used to describe the short-term effect. To avoid
overparameterization of the model, the intercept component of β2 has to be fixed or
removed, for example, by setting β20 = 0. With this coding of the model, the intercept term
in the first predictor (θ), β10, corresponds to the baseline log cure rate. With an exponential
parameterization of the predictors, the baseline survival function takes the form Ḡb(t|β0, z) =
exp{− exp(β10)[1 − γ̃(F̄|0)]}, where 0 = (0, 0, …)′ and β0 = ((β10, 0, 0, …), 0)′. As in the
Cox model (Cox 1972), the regression coefficients βij, i = 1, 2, j = 1, 2, …, correspond to the
relative effects of the covariates zij on the long- and short-term predictor, i = 1, 2,
respectively. For example, with the PHPH model, βij, i = 1, 2, j = 1, 2, …, is the log of the
hazard ratio in the two PH models of which the PHPH model is composed, corresponding to
the long- and short-term effect, i = 1, 2, respectively.
3.2 Estimation Procedures
The issue of the potentially infinite dimension has been the most critical deterrent to the use
of maximum likelihood estimation (MLE) in semiparametric regression models. Methods
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based on the partial likelihood are specific to the proportional hazards model and do not
extend to other models. The Newton–Raphson procedure requires taking the inverse of the
information matrix, which gets computationally prohibitive and unstable with increasing
dimension. Characterizing the future directions in survival analysis in their editorial in
Biometrics, Fleming and Lin (2000) pointed out that “it would be highly useful to develop
efficient and reliable numerical algorithms for the semiparametric estimation….” In the
following sections we review some recent approaches to the problem.
Introduce a set of times ti, i = 1, …, n, arranged in increasing order, with tn+1 = ∞.
Associated with each ti is a set of individuals  with covariates zij, j ∈ , who fail at ti, and
a similar set of individuals  with covariates zij, j ∈ , who are censored at ti. For any
function A(t) let Ai = A(ti) and ΔAi = |Ai − Ai−1|. The generalized log-likelihood for an NT
model (3.2) can be written as
(3.12)
3.2.1 Conventional Maximization Methods—Consider maximization of the log-
likelihood function ℓ(x) with respect to the joint vector of parameters x, representing
regression coefficients β and the nonparametrically specified function F. The vector ΔH
represents a set of jumps ΔHi of the cumulative hazard function H, which can be used to
parameterize F so that x = (β, ΔH). Consider a so-called direction sets method (Press,
Flannery, Teukolsky, and Vetterling 1994) constructed as follows:
1. Given the current iteration vector x(k), find the search direction s(k).
2. Maximize f (x(k) + ys(k)) with respect to the scalar y.
3. Set x(k+1) = x(k) = y*s(k), where y* is the solution at the previous step.
4. Set k = k + 1 and continue to step 1.
The Newton–Raphson method is one example of the direction sets methods. To avoid taking
the inverse of the full-model information matrix, the search direction s can be specified
according to the Powell method, which uses multiple line maximizations in one dimension
to construct a set of conjugate directions (Press et al., 1994).
3.2.2 Profile Likelihood Approach—Assume that we have a method to obtain the
global maximum of ℓ with respect to F, given β. We discuss two such methods in the next
two sections. We may write the profile log-likelihood as an implicit function of β:
(3.13)
where F* is the solution of the problem
(3.14)
where  is the class of proper discrete survival functions. A profile algorithm is a
straightforward nested procedure:
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• Maximize ℓpr(β) by a conventional nonlinear programming method (e.g., a
direction sets method).
• For any β as demanded in the preceding maximization procedure, solve the
problem (3.14) with specified tolerance.
Inference based on the profile likelihood is similar to that based on the partial likelihood for
the PH model. However, the classical theory of MLE does not apply to infinite dimensions.
Important results have been obtained regarding theoretical justifications for the
nonparametric maximum likelihood estimation (NPMLE) method and the profile likelihood
for semiparametric models (Murphy 2000). It was shown that profile likelihoods with
nuisance parameters estimated out behave like ordinary likelihoods under some conditions.
In particular, these results apply to the PH model, the proportional odds (PO) model, the PH
frailty model, and presumably to many other models.
3.2.3 Restricted Nonparametric Maximum Likelihood Estimation—Tsodikov
(2002) developed the so-called restricted nonparametric maximum likelihood estimation
(RNPMLE) algorithm. The RNPMLE method is based on a recurrent structure of the score
equations with respect to the nonparametric part of the model (F̄). Earlier variations of the
procedure were developed for the PH model (Tsodikov 1998a) and for the proportional odds
(PO) model (Tsodikov, Hasenclever, and Loeffler 1998a) and were subsequently
generalized for NT cure models (Tsodikov 2002). Although quite computationally intensive,
the RNPMLE method is numerically stable and it allows us to avoid taking inverses or
approximating the information matrix of the full model.
According to the nonparametric maximum likelihood method, the model can be fitted by
maximizing the generalized log-likelihood (3.12) with respect to the regression parameters β
and the unspecified survival function F̄ (or the corresponding distribution function F). In
doing so, the log-likelihood ℓ is maximized for a step function F with steps at the times of
failures.
As discussed earlier we impose the restriction F(tn) = 1. To maximize (3.12) under the





Inference procedures for the regression coefficients β can be obtained from the profile log-
likelihood (3.14). The profile log-likelihood is obtained by solving the score equations
(3.16) and (3.17) for F simultaneously, given β.
In the RNPMLE method the system of score equations (3.16) is partitioned into a subsystem
of the form
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that can be solved recurrently for F̄2, …, F̄n, given F0 = 0 and F1. Finally, the equation
ϕ(F̄1) = 1 is solved, where ϕ is defined as Fn generated recurrently using the subsystem
(3.18). The RNPMLE method yields point estimates and confidence intervals for the
regression coefficients and the function F (Tsodikov 2002).
3.2.4 EM-Based Methods—The EM algorithm used to fit shared frailty models in
survival analysis (Nielsen, Gill, Andersen, and Sørensen 1992) handles H in a numerically
efficient way. This is made possible as the M step reduces to the PH model. Estimates are
obtained iteratively by maximizing the partial likelihood and computing the Nelson–Aalen–
Breslow estimator (Andersen, Borgan, Gill, and Keiding 1993) for the cumulative hazard H.
Similar algorithms have been used to fit the two-component mixture model, given by Taylor
(1995), Sy and Taylor (2000, 2001), and Peng and Dear (2000).
Recently, Tsodikov (2003) generalized the EM algorithm for the frailty model into a
universal “distribution-free” procedure applicable to the general PH mixture model (3.5) and
NTM class (3.2). This family of algorithms (quasi-EM, QEM) is a subclass of the so-called
MM algorithms based on surrogate objective functions (Lange, Hunter, and Yang 2000).
Broadly defined, an MM algorithm substitutes a computationally simpler surrogate objective
function for the target function on each step of the procedure (similar to the E step of the
EM). Maximizing the surrogate objective function drives the target function in the desired
direction. Thus, a difficult maximization problem is replaced by a series of simpler ones.
Unfortunately, there is no universal recipe on how to find an appropriate surrogate objective
function. The idea of the QEM is to obtain a surrogate objective function by generalizing the
one inherent in the EM procedure so that it does not depend on the missing data formulation
of the model. Practically, the QEM approach for semiparametric models is based on a
derivation of the “distribution-free” E step for the EM algorithm, constructed for the PH
mixture model (3.5). More formally, we consider the QEM procedure for cure models. The
following statement is the key result underlying the QEM construction.
Proposition 3.1 (Tsodikov 2003): Let τ be the observed event time under independent
censoring and let c be the observed censoring indicator (c = 1, if a failure, and c = 0,
otherwise). Under the PH mixture model,
and if F′(τ) > 0, the conditional expectation of M, given the observed event, is given by
where
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where γ(c)(x|·) = ∂cγ (x|·)/∂xc, c = 0, 1, …, γ(0)(x|·) = γ (x|·).
The preceding result indicates that the E step can be constructed using the first two
derivatives of the NTM-generating function γ without any knowledge or even existence of
the mixing random variable M. Specification of an algorithm for a particular model requires
evaluation of Θ for the model. For example, for the models discussed in the previous
section, we have
• Improper PH model: From (3.1) or (3.7), Θ(x|·, c) = c + θ(·)x.
• PHPH model: From (3.11), Θ(x|·, c) = θ(·)η(·)xη(·) + cη(·).
Cure models require a correction of Θ at the last observation [see (3.21)]. Let cij = 1, j ∈ ,
and cij = 0, j ∈ . Let τk, k = 1, …, K, be the time points in ascending order where failures
occur (  is not empty). Denote by rk the rank of τk in the set {ti}. The ranks rk locate the
points τk on the set {ti: τk = trk}. By definition, we set τK +1 = n + 1 and τ0 = 0. Imputation of
the mixing variable M using (3.19) results in the score equations for the cumulative hazard
H corresponding to F,
(3.20)
where  is the risk set at tk, Dk is the number of failures at tk, and
(3.21)
where (·)ij stands for (β, zij). The fact that the contributions of the observations ij to the
likelihood as well as Θ at, or after the last failure (i ≥ rK), are different from their
counterparts before the last failure (i ≤ rK − 1) is due to the restriction F̄i = 0, i = rK, …, n,
representing the fact that F̄ is a proper survival function. This distinction is not made if the
model is a general NTM with an unrestricted F.
It is interesting to note that the score equations have the form of the Nelson–Aalen–Breslow
estimator for the PH model with the usual predictor replaced by Θ. Because Θ depends on F,
an iteration procedure is needed to satisfy (3.20). Given β, iterations with respect to F can be
carried out as follows:
• At the kth iteration F̄(k), compute Θ(k) for each subject.
• Update F(k) by F(k+1) using the Nelson–Aalen–Breslow estimator (3.20).
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It can be shown (Tsodikov 2003) that if Θ(x|·) is a nondecreasing function of x, or if γ is a
PH mixture model (a stronger assumption), then each iteration described previously
improves the likelihood. Also, this assumption makes the preceding procedure a member of
the MM family (Lange et al. 2000), and the convergence properties of the algorithm follow
from the general MM theory.
There are many ways to build a particular model fitting algorithm based on the principles
described previously, and this depends on how the maximization with respect to β is
incorporated into the procedure. One way would be to use partial likelihood and a setup
similar to the EM algorithm for frailty models (Nielsen et al. 1992). Such an EM algorithm
was used in Sy and Taylor (2000) and Peng and Dear (2000) to fit the two-component
mixture model. As simple as the setup of the procedure with a binary distribution for M
might be, its generalization for a wider family of PH mixture models or NTM’s is
problematic. The key to a straightforward setup of the procedure is not to use the EM
principle on β, as it would require working with the distribution of M.
We find the profile version of the QEM algorithm particularly easy and straightforward to
work with. The profile QEM algorithm outperformed conventional maximization procedures
(Sec. 3.2.1) and the frailty EM algorithm based on partial likelihood when used to fit a
semiparametric proportional odds (PO) model. Also, it was shown to be faster than a
directions set method used to fit a parametric PO model.
3.3 Example: Prostate Cancer Data
The study was carried out using data on 1,100 patients with clinically localized prostate
cancer who were treated with three-dimensional conformal radiation therapy at the
Memorial Sloan-Kettering Cancer Center (Zaider et al. 2001). The patients were stratified
by radiation dose (group 1, <67.5 Gy; group 2, 67.5–72.5 Gy; group 3, 72.5–77.5 Gy; group
4, 77.5–87.5 Gy) and prognosis category [favorable, intermediate, and unfavorable as
defined by pretreatment prostate specific antigen (PSA) measurement and Gleason
prognostic score]. A relapse was recorded when tumor recurrence was diagnosed or when
three successive PSA elevations were observed from a post-treatment nadir PSA level. PSA
relapse-free survival was used as the primary endpoint. There were no failures observed in
patients with favorable prognosis in dose group 4. For that reason this group of patients is
not included in the data analysis.
We applied the PHPH extended hazard model (3.11) with z specified by indicator dummy
variables that code the four dose groups and the three prognostic categories. In the
unrestricted model dose and summary prognosis may each have an effect on long-term
survival through θ(z) and on short-term survival through η(z). The hypothesis of no short-
term effect of prognostic category (proportional hazards with respect to prognosis) is not
rejected (p = .49) by the likelihood ratio test. This observation justifies the use of the PH
model for the effect of the prognostic category. However, the total radiation dose appears to
have a significant (p < .0001) short-term effect on survival of patients with prostate cancer,
indicating nonproportionality of the effect of dose. Resorting to our mechanistic
interpretation of (3.11), we may speculate that the progression time distribution varies with
radiation dose while being essentially the same for all prognostic categories. Semiparametric
estimates of the mean values for the distributions 1 − γ (F̄|z) are equal to 1,279, 867, 803,
and 498 days for dose groups 1, 2, 3, and 4, respectively. Estimates of the hazard ratio for
the short-term effect of each dose group,
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show a monotonically increasing (with dose) short-term risk: .188 with confidence limits (.
038, 1.538) for dose group 1, .415 (.065, .765) for dose group 2, .474 (.024, 1.224) for dose
group 3, and 1.000 for dose group 4.
Semiparametric estimates of the probability of cure are given in Table 1. For comparison,
we also present parametric estimates obtained with F specified by a two-parameter gamma
distribution. It is shown in Table 1 that the two estimates appear to be quite close to each
other. This analysis indicates that, in terms of cure rate, dose escalation has a significant
positive effect only in the intermediate and unfavorable groups. It is also found that
progression time is inversely proportional to dose, which means that patients recurring in
higher dose groups have shorter recurrence times, yet these groups have better long-term
survival. One possible explanation for this seemingly illogical observation lies in the fact
that less aggressive tumors potentially recurring after a long period of time are cured by
higher doses and do not contribute to the observed time pattern of tumor relapse. As a result
tumors in higher dose groups are less likely to recur; however, if they do, they tend to recur
earlier.
4. BAYESIAN INFERENCE
4.1 Parametric Cure Rate Model
Ibrahim, Chen, and Sinha (2001a) presented a comprehensive treatment of Bayesian
approaches for the cure rate model
(4.1)
We review some of their work here. We let the covariates depend on θ through the
relationship θ = exp(x′β), where x is a p × 1 vector of covariates and β = (β1, …, βp) is a p ×
1 vector of regression coefficients. Proceeding from the biological interpretation discussed
in Section 1, we can now construct the likelihood function (see Chen et al. 1999; Ibrahim et
al. 2001a) in a typical setting. Suppose we have n subjects and let Ni denote the number of
surviving clonogenic tumor cells for the ith subject. Further, we assume that the Ni’s are
i.i.d. Poisson random variables with mean θ, i = 1,2, …, n. We emphasize here that the Ni’s
are not observed and can be viewed as latent variables in the model formulation. Further,
suppose Zi1, Zi2, …, Zi, Ni are the i.i.d. progression times for the Ni cells for the ith subject,
which are unobserved, and all have proper cumulative distribution function F (·), i = 1,2, …,
n. We denote the indexing parameter (possibly vector valued) by ψ, and thus write F(·|ψ)
and F̄(·|ψ) = 1 − F (·|ψ). For example, if F (·|ψ) corresponds to a Weibull distribution, then
ψ = (α, λ)′, where α is the shape parameter and λ is the scale parameter. Let yi denote the
survival time for subject i, which may be right censored, and let νi denote the censoring
indicator, which equals 1 if yi is a failure time and 0 if it is right censored. The observed data
are Dobs = (n, y, ν), where y = (y1, y2, …, yn)′ and ν = (ν1, ν2, …, νn)′. Also, let N = (N1, N2,
…, Nn)′. The complete data are given by D = (n, y, ν, N), where N is an unobserved vector
of latent variables. Throughout the remainder of this section, we will assume a Weibull
density for f (yi|ψ), so that f (y|ψ) = αyα−1 exp{λ − yα exp(λ)}. When covariates are included
we have a different cure rate parameter, θi, for each subject, i = 1, 2, …, n. Let
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 denote the p × 1 vector of covariates for the ith subject. We relate θ to the
covariates by , so that the cure rate for subject i is
, i = 1, 2, …, n. This relationship between θi and β is equivalent to
a canonical link for θi in the setting of Poisson regression models. With this relation we can
write the complete data likelihood of (β, ψ) as
(4.2)
where D = (n, y, X, ν, N), X is the n × p matrix of covariates, f (yi|ψ) is the Weibull density
given previously, and .
Chen et al. (1999) discussed classes of noninformative priors as well as the class of power
priors for (β, ψ) and examined some of their properties. Consider the joint noninformative
prior π(β, ψ) ∝ π(ψ), where ψ = (α, λ)′ are the Weibull parameters in f (y|ψ). This
noninformative prior implies that β and ψ are independent a priori and π(β) ∝ 1 is a uniform
improper prior. We will assume throughout this section that π(ψ) = π(α|δ0, τ0)π(λ), where
π(α|δ0, τ0) ∝ αδ0−1 exp(−τ0α) and δ0 and τ0 are two specified hyperparameters. Although
several choices can be made, we will use a normal density for π(λ). With these specifications
the posterior distribution of (β, ψ) based on the observed data Dobs = (n, y, X, ν) is given by
(4.3)
where the sum in (4.3) extends over all possible values of the vector N. Chen et al. (1999)
gave conditions concerning the propriety of the posterior distribution in (4.3) using the non-
informative prior π(β,ψ) ∝ π(ψ). This enables us to carry out Bayesian inference with
improper priors for the regression coefficients and facilitates comparisons with maximum
likelihood. However, under the improper priors π(β, ψ) ∝ π(ψ), the mixture model in (1.2)
always leads to an improper posterior distribution for β as shown in Chen et al. (1999).
Ibrahim and Chen (2000) described a general class of informative priors called the power
priors for conducting Bayesian inference in the presence of historical data. We now examine
the power priors for (β, ψ). Let n0 denote the sample size for the historical data, let y0 be an
n0 × 1 of right-censored failure times for the historical data with censoring indicators ν0, let
N0 be the unobserved vector of latent counts of clonogenic cells, and let X0 be an n0 × p
matrix of covariates corresponding to y0. Let D0 = (n0, y0, X0, ν0, N0) denote the complete
historical data. Further, let π0(β, ψ) denote the initial prior distribution for (β, ψ). A beta
prior is chosen for a0, leading to the joint power prior distribution
(4.4)
where L(β, ψ|D0) is the complete data likelihood given in (4.2) with D being replaced by the
historical data D0 and D0,obs = (n0, y0, X0, ν0). We take a noninformative prior for π0(β, ψ),
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such as π0(β, ψ) ∝ π0(ψ), which implies π0(β) ∝ 1. For ψ = (α, λ)′ we take a gamma prior for
α with small shape and scale parameters and an independent normal prior for λ with mean 0
and variance c0. Also, (γ0, λ0) are specified prior parameters. The prior in (4.4) does not
have a closed form but has several attractive properties. First, we note that if π0(β, ψ) is
proper, then (4.4) is guaranteed to be proper. Further, (4.4) can be proper even if π0(β, ψ) is
improper. Chen et al. (1999) characterized the propriety of (4.4) when π0(β, ψ) is improper.
In addition, they showed that the power prior for β based on the model (1.2) will always lead
to an improper prior as well as an improper posterior distribution.
4.2 Semiparametric Cure Rate Model
In this section we consider a semiparametric version of the parametric cure rate model
discussed in the previous section. Following Ibrahim et al. (2001a), Chen, Harrington, and
Ibrahim (2001), and Chen and Ibrahim (2001), we construct a finite partition of the time
axis, 0 < s1 < ··· < sJ, with sJ > yi for all i = 1, 2, …, n. Thus, we have the J intervals (0, s1],
(s1, s2], …, (sJ − 1, sJ], and we assume that the hazard for F(y) is equal to λj for the jth
interval, j = 1, 2, …, J, leading to
(4.5)
where λ = (λ1, …, λJ)′. We note that, when J = 1, F *(y|λ1) reduces to the parametric
exponential model. With this assumption the complete data likelihood can be written as
(4.6)
where νij = 1 if the ith subject failed or was censored in the jth interval, and 0 otherwise. The
model in (4.6) is a semiparametric version of (4.2) in which the degree of the
nonparametricity is controlled by J. Because the estimation of the cure rate parameter θ
could be highly affected by the nonparametric nature of F*(y|λ), it may be desirable to
choose small to moderate values of J for cure rate modeling. In practice, we recommend
doing analyses for several values of J to see the sensitivity of the posterior estimates of the
regression coefficients. The semi-parametric cure rate model (4.6) is quite flexible, as it
allows us to model general shapes of the hazard function, as well as choose the degree of
parametricity in F*(y|λ) through suitable choices of J. Again, because N is not observed, the
observed data likelihood, L(β, λ|Dobs), is obtained by summing out N from (4.6) as in the
previous section. Also, power priors for this model can be constructed in a similar fashion as
in the previous section. We refer the reader to Ibrahim et al. (2001a),Chen et al. (2001), and
Chen and Ibrahim (2001) for more details.
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4.3 An Alternative Semiparametric Cure Rate Model
A crucial issue with cure rate modeling, and semiparametric survival models in general, is
the behavior of the model in the right tail of the survival distribution. In these models there
are typically few subjects at risk in the tail of the survival curve after sufficient follow-up;
therefore, estimation of the cure rate can be quite sensitive to the choice of the semi-
parametric model. Thus, there is a need to carefully model the right tail of the survival curve
and allow the model to be more parametric in the tail, while also allowing the model to be
non-parametric in other parts of the curve. Ibrahim, Chen, and Sinha (2001b) constructed
such a model by defining a smoothing parameter κ, 0 < κ < 1, that controls the degree of
parametricity in the right tail of the survival curve and does not depend on the data.
Specifically, the prior for λj depends on κ, such that the model converges to a parametric
model in the right tail of the survival curve as j → ∞. By an appropriate choice of κ, one can
choose a fully nonparametric model or a fully parametric model for the right tail of the
survival distribution. Also, κ will allow some control over the degree of parametricity in the
beginning and middle part of the survival distribution. A more parametric shape of the
model in the right tail facilitates more stable and precise estimates of the parameters. This
approach is fundamentally very different from previous approaches for semiparametric
Bayesian survival analysis, which primarily focus on specifying a prior process with a mean
function and possibly a smoothing parameter, in which the posterior properties of both of
them depend on the data.
Let F0(t|ψ0) denote the parametric survival model chosen for the right tail of the survival
curve and let H0(t) denote the corresponding cumulative baseline hazard function. Now take




where 0 < κ < 1 is the smoothing parameter. As κ → 0, , so that small values of κ
imply a more parametric model in the right tail. In addition, as j → ∞, , implying
that the degree of parametricity is increased at a rate governed by κ as the number of
intervals increases. This property also implies that, as j → ∞, the survival distributionin the
right tail becomes more parametric regardless of any fixed value of κ. The properties of this
model are attractive. For example, if F0(·|ψ0) is an exponential distribution, then F0(y|ψ0) =
1 − exp(−ψ0y), so that μj = ψ0 and . If F0(·|ψ0) is a Weibull distribution, then F0(y|
ψ0) = 1 − exp(−γ0yα0), ψ0 = (α0, γ0)′, so that
Several properties of this model are now given, which are proved in Ibrahim et al. (2001a,b).
Tsodikov et al. Page 20













Property 4.1—Assume that (sj + sj−1)/2 → t as sj − sj−1 → 0. Then, for any j, according to
this prior process, E(λj|ψ0) → h0(t) as sj − sj−1 → 0, where .
For example, if F0(y|ψ0) = 1 − exp(−ψ0y), then E(λj|ψ0) = ψ0 regardless of the choice of s1,
s2, …, sJ. If F0(y|ψ0) = 1 − exp(−γ0yα0), then E(λj |ψ0) → γ0α0tα0−1 as sj − sj −1 → 0. This
assures that, as j becomes large and sj − sj−1 → 0, this prior process approximates any prior
process with prior mean h0(t) defined on the progression time hazard h*(t|λ) corresponding
to (4.5).
Property 4.2—Let . Then  as κ → 0, where
F̄p(y|ψ0) = exp(−θF0(y|ψ0)).
Property 4.3—Let  and let  denote the corresponding
hazard function. Then  as κ → 0, where .
We now give joint prior specifications for the semiparametric model in (4.7) and (4.8). We
specify a hierarchical model and first consider a joint (improper) noninformative prior
distribution for (β, λ, ψ0), given by
(4.9)
We take each π(λj|ψ0) to be independent gamma densities with mean μj and variance . If
F0(·|ψ0) is an exponential distribution, then ψ0 is a scalar, and we specify a gamma prior for
it; that is, , where ζ0 and τ0 are specified hyperparameters. If F0(·|
ψ0) is a Weibull distribution, then ψ0 = (α0, γ0)′. In this case we take a prior of the form
(4.10)
where ζα0, τα0, ζγ0, and τγ0 are specified hyperparameters. For β we consider a uniform
improper prior. Ibrahim et al. (2001a, 2001b) established conditions for the propriety of the
joint posterior distribution of (β, λ, ψ0), when using an exponential distribution or a Weibull
distribution for F0(·|ψ0). In addition, they developed the power prior for this model.
4.4 Multivariate Cure Rate Model
It is often of interest to jointly model several types of failure time random variables in
survival analysis, such as time to cancer relapse at two different organs, times to cancer
relapse and death, times to first and second infection, and so forth. In addition, these random
variables typically have joint and marginal survival curves that “plateau” beyond a certain
period of follow-up; therefore, it is of great importance in these situations to develop a joint
cure rate model for inference. There does not appear to be a natural multivariate extension of
the mixture model in (1.2). Even if such an extension were available, it appears that a
multivariate mixture model would be extremely cumbersome to work with from a
theoretical and computational perspective. As an alternative to a direct multivariate
extension of (1.2), Chen, Ibrahim, and Sinha (2001) proposed a multivariate generalization
of (4.1), called the multivariate cure rate model. This model proves to be quite useful for
Tsodikov et al. Page 21













modeling multivariate data in which the joint failure time random variables have a surviving
fraction and each marginal failure time random variable also has a surviving fraction. To
induce the correlation structure between the failure times, Chen et al. (2001) introduced a
frailty term (Clayton 1978;Hougaard 1986;Oakes 1989), which is assumed to have a positive
stable distribution. A positive stable frailty results in a conditional proportional hazards
structure (i.e., given the unobserved frailty). Thus, the marginal and conditional hazards of
each component have a proportional hazards structure and remain in the same class of
univariate cure rate models.
For clarity and ease of exposition, we will focus our discussion on the bivariate cure rate
model, as extensions to the general multivariate case are quite straightforward. The bivariate
cure rate model of Chen et al. (2001) can be derived as follows. Let Y = (Y1, Y2)′ be a
bivariate failure time, such as Y1 = time to cancer relapse and Y2 = time to death, or Y1 =
time to first infection and Y2 = time to second infection, and so forth. We assume that (Y1,
Y2) are not ordered and have support on the upper orthant of the plane. For an arbitrary
patient in the population, let N = (N1, N2)′ denote latent (unobserved) variables for (Y1, Y2),
respectively. We assume throughout that Nk has a Poisson distribution with mean θkw, k = 1,
2, and (N1, N2) are independent, given w. The quantity w is a frailty component in the model
that induces a correlation between the latent variables (N1, N2). Here we take w to have a
positive stable distribution indexed by the parameter α, denoted by w ~ Sα(1, 1, 0), where 0
< α < 1 (see Chen et al. 2001 for more details). Although several choices can be made for
the distribution of w, the positive stable distribution is quite attractive, common, and flexible
in the multivariate survival setting. In addition, it will yield several desirable properties.
Let Zi = (Z1i, Z2i)′ denote the bivariate progression time for the ith clonogenic cell. The
random vectors Zi, i = 1, 2, …, are assumed to be independent and identically distributed.
The cumulative distribution function of Zki is denoted by Fk (t) = 1 − F̄k(t), k = 1, 2, and Fk
is independent of (N1, N2). The observed survival time can be defined by the random
variable Yk = min{Zki, 0 ≤ i ≤ Nk}, where P (Zk0 = ∞) = 1 and Nk is independent of the
sequence Zk1, Zk2, …, for k = 1, 2. The survival function for Y = (Y1, Y2)′, given w, and
hence the survival function for the population, given w, is given by
(4.11)
where P (Nk = 0) = P (Yk = ∞) = exp(−θk), k = 1, 2. The frailty variable w serves a dual
purpose in the model—it induces the correlation between Y1 and Y2 and at the same time
relaxes the Poisson assumption of N1 and N2 by adding the same extra Poisson variation
through their respective means θ1w and θ2w.
The Laplace transform of w is given by E(exp(−sw)) = exp(−sα). Using the Laplace
transform of w, a straightforward derivation yields the unconditional survival function
(4.12)
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It can be shown that (4.12) has a proportional hazards structure if the covariates enter the
model through (θ1, θ2). The joint cure fraction implied by (4.12) is F̄pop(∞, ∞) = exp(−[θ1
+ θ2]α). From (4.12) the marginal survival functions are , k = 1, 2.
Equation (4.12) indicates that the marginal survival functions have a cure rate structure with
probability of cure  for Yk, k = 1, 2. It is important to note in (4.12) that each
marginal survival function has a proportional hazards structure as long as the covariates, x,
only enter through θk. The marginal hazard function is given by , with
attenuated covariate effect (θk(x))α, and fk(y) is the survival density corresponding to Fk(y).
This property is similar to the earlier observations made by Oakes (1989) for the ordinary
bivariate stable frailty survival model. The parameter α, 0 < α < 1, is a scalar parameter that
is a measure of association between (Y1, Y2). Small values of α indicate high association
between (Y1, Y2). As α → 1 this implies less association between (Y1, Y2), which can be seen
from (4.12). Following Clayton (1978) and Oakes (1989), we can compute a local measure
of dependence, denoted θ*(y1, y2), as a function of α. For the multivariate cure rate model in
(4.12), θ*(t1, t2) is well defined and is given by
(4.13)
We see that θ*(y1, y2) in (4.13) decreases in (y1, y2). That is, the association between (Y1, Y2)
is greater when (Y1, Y2) are small and the association decreases over time. Such a property is
desirable, for example, when Y1 denotes time to relapse and Y2 denotes time to death.
Finally, we mention that a global measure of dependence such as Kendall’s τ or the Pearson
correlation coefficient is not well defined for the multivariate cure rate model (4.12) because
no moments for cure rate models exist due to the improper survival function.
The likelihood function for this model based on n subjects can be written as
(4.14)
where ψ = (ψ1, ψ2), θ = (θ1, θ2), Nki is the number of clonogens for the ith subject, and
fk(yki|ψk) is the density corresponding to Fk(yki|ψk), i = 1, …, n, k = 1,2. Chen et al. (2001)
used a Weibull density for fk (yki|ψk), so that fk(y|ψk) = ξkyξk−1 exp{λk − yξk exp(λk)}, where
ψk = (ξk, λk), k = 1, 2. To construct the likelihood function of the observed data, we integrate
(4.14) with respect to (N, w) assuming an Sα(1, 1, 0) density for each wi, denoted by fs (wi|
α), where N = (N11, …, N1n, N21, …, N2n) and w = (w1, …, wn). As before we incorporate
covariates for the cure rate model (4.12) through the cure rate parameter θ. Let
 denote the p × 1 vector of covariates for the ith subject and let βk = (βk1,
βk2, …, βkp)′ denote the corresponding vector of regression coefficients for failure time
random variable Yk, k = 1, 2. We relate θ to the covariates by , so that
the cure rate for subject i is  for i = 1, 2, …, n and k = 1, 2. Letting
, Chen et al. (2001) showed that the observed data likelihood of (β, ψ, α) can be
written as
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where  consists of those patients who failed according to Yk, k = 1, 2, Dobs = (n, y1, y2, X,
ν1, ν2), X is the n × p matrix of covariates, fk (yki|ψk) is Weibull, and
.
Chen et al. (2001) considered a joint improper prior for (β, ψ, α) = (β1, β2, ψ1, ψ2, α) of the
form
where I (0 < α < 1) = 1 if 0 < α < 1, and 0 otherwise. This prior implies that β, ψ, and α are
independent a priori, (β1, β2) are independent a priori with an improper uniform prior, α has
a proper uniform prior over the interval (0, 1), and (ψ1, ψ2) are independent and identically
distributed as π(ψk) a priori. Chen et al. (2001) assumed that π(ξk, λk) = π(ξk|ν0, τ0)π(λk),
where
and δ0, τ0, and c0 are specified hyperparameters. Chen et al. (2001) and Ibrahim et al.
(2001a) gave a detailed discussion of the computational implementation of this model.
Detailed real data examples for the models discussed in Sections 4.1–4.3 can be found in
Ibrahim et al. (2001a). The Gibbs sampler was used to obtained posterior estimates for all
models discussed in this section. Details of the Gibbs sampling algorithms and covergence
diagnostics can be found in Ibrahim et al. (2001).
5. FUTURE RESEARCH
Future areas of research include expanding the Bayesian model to include covariates in θ as
well as F (t). Although not investigated here, this appears to be a natural extension of the
Bayesian model presented in Section 4. A more general regression model is currently being
investigated. The results reported in Section 3 from the frequentist perspective also
encourage this research effort.
Tsodikov et al. Page 24













The class of models given by expression (1.8) in Section 1 opens a new avenue in
parametric (and probably semiparametric; see Section 3) survival regression. For example,
by incorporating a predictor into the parameter i we obtain a proportional hazards (PH)
model. The quantity i is unobservable, but it is reasonable to assume that i is proportional to
the observable tumor volume. If one predictor is incorporated into the parameter i whereas
another covariate (e.g., fractional radiation dose) is incorporated into some other
parameter(s) of the model, the resulting regression counterpart of (1.8) will no longer be the
PH model. From a statistical viewpoint the main advantage of this generalization of the
clonal model of tumor recurrence is that it can suggest the structure of new regression
models to be further explored by statistical methods. Such models may provide a useful
means of searching for better regimens for fractionated radiotherapy.
Another promising idea is to explore possible links between stochastic models proposed for
the natural history of cancer and for posttreatment cancer survival; this approach can enrich
statistical inference by supplementing the analysis of patients’ survival with additional
epidemiological data on cancer detection. We believe that this idea may dramatically change
the whole concept of modern parametric survival analysis, by invoking mechanistically
motivated models for the joint distribution of covariates at the time of diagnosis.
Methods for model diagnostics especially designed for the semiparametric models in Section
3 remain a very important issue for future methodological research. The same is equally true
for the regression counterparts of the two-component mixture model. Justification of
asymptotic properties of the estimate represent a serious challenge.
6. SOFTWARE AND DATA ANALYSIS FOR CURE RATE MODELS
Prototype software implementing the estimation procedures of Section 3.2 was programmed
in Delphi 6.0 for Windows 95/98/2000/XP, an object-oriented visual development
environment based on the Pascal programming language by INPRISE™. This software is
available on request from Alex Tsodikov. Implementation of these methods in high-level
languages such as R, S, or SAS appears straightforward. In addition, Extensive BUGS
software is available for the cure rate and other related models given in the book by Ibrahim
et al. (2001a). This software can be easily downloaded from the book’s Web site at
http://www.merlot.uconn.edu/mhchen/survbook. BUGS code for several models and
datasets is available from this Web site.
In the semiparametric context a cure model can be regarded as a convenient
reparameterization of its counterpart in the noncure form [compare the traditional form of
the PH model G = F̄θ with its cure form (3.1)]. A display of the Kaplan–Meier estimator for
the data may indicate a noncure situation if the curves go to 0 at the end of follow-up. Fitting
a cure form model to such data may result in numerical instability as the parameter coding
the cure rate would be approaching the border of the parametric space.
Departures from proportionality and an indication for the extended hazard models can be
explored using an empirical display of the function F (2.4) or its more sophisticated versions
as discussed in Section 2. Similar techniques for model exploration is available for two-
component mixture models (Tsodikov 2002). More work is needed to create a toolbox of
methods for model building, choice and diagnostics.
7. BIBLIOGRAPHICAL NOTES
Over recent years the BCH model has been developed in many different directions. In
particular, the literature on parametric inference based on this model is quite voluminous.
The usual practice is to use the two-parameter gamma or the Weibull distribution for the
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function F(t) in formula (1.4). Maximum likelihood inference without covariates has been
discussed in the context of right-censored data under continuous follow-up (Asselain,
Fourquet, Hoang, Myasnikova, and Yakovlev 1994;Hoang, Tsodikov, Yakovlev, and
Asselain 1995;Yakovlev 1996;Yakovlev and Tsodikov 1996); discrete surveillance design
(Tsodikov, Asselain, Fourquet, Hoang, and Yakovlev 1995), and doubly censored data
(Kruglikov, Pilipenko, Tsodikov, and Yakovlev 1997). A version of the Hjort goodness-of-
fit test for the model (1.4) with F (t) represented by the gamma distribution was described in
Gregori et al. (2002). Tsodikov (1998a) studied the asymptotic efficiency of cure rate
estimation. Some limiting distributions associated with model (4.1) and their bivariate
counterparts were described in the articles by Klebanov, Rachev, and Yakovlev (1993a) and
Rachev, Wu, and Yakovlev (1995); the authors also provided estimates of the convergence
rates. Parametric and semiparametric regression models allowing for dissimilar effects of
covariates on the probability of cure and the timing of the event of interest were extensively
explored in several publications (Asselain, Fourquet, Hoang, Tsodikov, and Yakovlev
1996;Tsodikov et al. 1998b;Myasnikova, Asselain, and Yakovlev 2000;Tsodikov 2002). An
improper proportional hazards model was studied by Tsodikov (1998a,b) and Chen and
Ibrahim (2001). Time-dependent risk factors for the cure probability were introduced in
Tsodikov et al. (1997,1998b) and Tsodikov and Müller (1998). Two-sample score tests for
long-term and short-term effects on survival were proposed by Broët et al. (2001). Statistical
inference from the Bayesian prospective was discussed by Klebanov, Rachev, and Yakovlev
(1993b),Chen et al. (1999,2001), Ibrahim and Chen (2000),Ibrahim et al. (2001a,b), and
Chen, Ibrahim, and Lipsitz, (2002). Ibrahim et al. (2001a) devoted an entire chapter (chap.
5) to the cure rate model and its applications in their book. Moreover, recent books
discussing Gibbs sampling for this model and related models are also given in Ibrahim et al.
(2001a) and Chen, Shao, and Ibrahim (2000). The model has successfully been applied to
various datasets on cancer survival (Yakovlev et al. 1993;Asselain et al.
1994,1996;Yakovlev 1996;Yakovlev and Tsodikov 1996;Tsodikov et al.
1995,1997;Tsodikov 1998a,Tsodikov et al. 1998b;Chen et al. 1999;Yakovlev et al.
1999;Myasnikova et al. 2000;Trelford, Tsodikov, and Yakovlev 2001;Tsodikov
2001,2002;Tsodikov, Dicello, Zaider, Zorin, and Yakovlev 2001;Zaider et al. 2001;Zorin,
Tsodikov, Zharinov, and Yakovlev 2001).
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(a) Relapse-Free Survival for Patients With Hodgkin’s Disease Treated by Radiotherapy.
Data from the International Database on Hodgkin’s Disease. (b) Breast cancer specific
survival in local stage by age. Data from the Surveillance Epidemiology and End Results
Program.
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Table 1
Estimates of the Probability of Cure (semiparametric/parametric) and 95% Semiparametric Likelihood Ratio




1 2 3 4
Favorable .78/.80 .79/.74 .88/.87 1.00*
(.55, .95) (.68, .92) (.80, .97) –
Intermediate .37/.25 .53/.51 .67/.58 .79/.74
(.21, .55) (.41, .64) (.58, .78) (.68, .87)
Unfavorable .02/.00 .35/.27 .46/.33 .60/.64
(.00, .11) (.25, .45) (.38, .56) (.45, .74)
*
The estimate of the probability of cure is set equal to 1 because no failures are observed in this group of patients.
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